EGFR and lung carcinoma: Based on a GSEA of all differentially expressed genes, various significantly enriched signaling pathways were identified, including EGFR signaling, lung cancer poor survival, undifferentiated cancer, proliferation, and cell cycle, as determined by the normalized enrichment score (NES), adjusted P-value, and false discovery rate (FDR) (Figure 7A–7D).